Product catalog antigen listed by alphabetic starting with B
| Items 301 to 400 of 552 total | 6 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00027345-P01-10 | BK channel subunit beta-4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00027345-P01-25 | BK channel subunit beta-4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010563-Q01-10 | BLC / CXCL13 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010563-Q01-25 | BLC / CXCL13 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA137 | BLC / CXCL13 antigen | ||||||
| Human | >98% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA137X | BLC / CXCL13 antigen | ||||||
| Human | >98% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA185 | BLC / CXCL13 antigen | ||||||
| Mouse | Purified | >98% | E. coli | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA185X | BLC / CXCL13 antigen | ||||||
| Mouse | Purified | >98% | E. coli | 20 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| H00000640-P01-10 | BLK antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000640-P01-25 | BLK antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000640-Q01-10 | BLK antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000640-Q01-25 | BLK antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000641-Q01-10 | BLM antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000641-Q01-25 | BLM antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000642-Q01-10 | BLMH antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000642-Q01-25 | BLMH antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029760-Q01-10 | BLNK / SLP-65 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029760-Q01-25 | BLNK / SLP-65 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002647-Q01-10 | BLOC1S1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002647-Q01-25 | BLOC1S1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000643-Q01-10 | BLR1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000644-P01-10 | BLVRA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000644-P01-25 | BLVRA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000645-Q01-10 | BLVRB antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000645-Q01-25 | BLVRB antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008548-Q01-10 | BLZF1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008548-Q01-25 | BLZF1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055839-P01-10 | BM039 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055839-P01-25 | BM039 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX24959 | BMAL1 peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29654 | Bmf peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29656 | Bmf peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| H00025805-P01-10 | BMP and Activin Membrane-bound Inhibitor Homolog antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00025805-P01-25 | BMP and Activin Membrane-bound Inhibitor Homolog antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000649-Q01-10 | BMP1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000649-Q01-25 | BMP1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00027302-P01-10 | BMP10 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00027302-P01-25 | BMP10 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00027302-Q01-10 | BMP10 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00027302-Q01-25 | BMP10 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000650-Q01-10 | BMP2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000650-Q01-25 | BMP2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055589-Q01-10 | BMP2K antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055589-Q01-25 | BMP2K antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000651-Q01-10 | BMP3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000651-Q01-25 | BMP3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000653-Q01-10 | BMP5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000653-Q01-25 | BMP5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000654-Q01-10 | BMP6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000654-Q01-25 | BMP6 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000655-P01-10 | BMP7 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000655-P01-25 | BMP7 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000656-Q01-10 | BMP8B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000656-Q01-25 | BMP8B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000657-P01-10 | BMPR1A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000657-P01-25 | BMPR1A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000657-Q01-10 | BMPR1A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000657-Q01-25 | BMPR1A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000658-P01-10 | BMPR1B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000658-P01-25 | BMPR1B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000658-Q01-10 | BMPR1B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000658-Q01-25 | BMPR1B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000660-Q01-10 | BMX antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000660-Q01-25 | BMX antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000646-Q01-10 | BNC1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000646-Q01-25 | BNC1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000662-P01-02 | BNIP1 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000662-P01-10 | BNIP1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000662-P01-25 | BNIP1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000665-Q01-10 | BNIP3L antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000665-Q01-25 | BNIP3L antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX28431 | BNIP3L peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| H00149428-P01-02 | BNIPL antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00149428-P01-10 | BNIPL antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00149428-P01-25 | BNIPL antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 8BFP | BNP and NT-proBNP free plasma antigen | ||||||
| Human | Plasma | 0,5 mg / --- | |||||
| HyTest Ltd. | |||||||
| H00091653-P01-10 | BOC antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00091653-P01-25 | BOC antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000666-Q01-10 | BOK antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000666-Q01-25 | BOK antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051027-Q01-10 | BOLA1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051027-Q01-25 | BOLA1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00066037-Q01-10 | BOLL antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00066037-Q01-25 | BOLL antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000680-Q01-10 | Bombesin Receptor Subtype 3 (BRS3) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000680-Q01-25 | Bombesin Receptor Subtype 3 (BRS3) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA213 | Bone Morphogenetic Protein 13 (BMP13) antigen | ||||||
| Human | Purified | >98% | E. coli | 10 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA213X | Bone Morphogenetic Protein 13 (BMP13) antigen | ||||||
| Human | Purified | >98% | E. coli | 50 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| BMP135-R-10 | Bone Morphogenetic Protein 13 (BMP13) antigen | ||||||
| Purified | - | 10 µg / --- | |||||
| Alpha Diagnostic Intl. Inc. | |||||||
| BMP135-R-50 | Bone Morphogenetic Protein 13 (BMP13) antigen | ||||||
| Human | Purified | - | 50 µg / --- | ||||
| Alpha Diagnostic Intl. Inc. | |||||||
| BMP145-R-10 | Bone Morphogenetic Protein 14 (BMP14) antigen | ||||||
| Human | Purified | - | 10 µg / --- | ||||
| Alpha Diagnostic Intl. Inc. | |||||||
| BMP145-R-50 | Bone Morphogenetic Protein 14 (BMP14) antigen | ||||||
| Human | Purified | - | 50 µg / --- | ||||
| Alpha Diagnostic Intl. Inc. | |||||||
| DA3502 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >95% | E. coli | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| DA3502X | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >95% | E. coli | 25 µg / US$ 515 | |||
| Acris Antibodies GmbH | |||||||
| PA212 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >98% | E. coli | 2 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA212X | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >98% | E. coli | 10 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| BMP25-R | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >95% | CHO cells | 10 µg / --- | |||
| Alpha Diagnostic Intl. Inc. | |||||||
| BMP25-R-10 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | - | 10 µg / --- | ||||
| Alpha Diagnostic Intl. Inc. | |||||||
| PR15013-10 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >90% | CHO cells | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15014-10 | Bone Morphogenetic Protein 2 (BMP2) antigen | ||||||
| Human | Purified | >95% | E. coli | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15013CF-10 | Bone Morphogenetic Protein 2 (BMP2) (Carrier Free) antigen | ||||||
| Human | Purified | >95% | CHO cells | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| Items 301 to 400 of 552 total | 6 Page(s): |



